Search Results for "Distributor Of Genway In India"

15:21 EDT 31st October 2014 | BioPortfolio

Original Source: GenWay Biotech, Inc

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date, ...

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Matching News

NOVADAQ Appoints Kirloskar Technologies as Its Exclusive Distributor in India

TORONTO, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Novadaq® Technologies Inc. ("NOVADAQ" or the "Company") (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence ima...

Novadaq signs India distribution deal with Kirloskar

Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has appointed Kirloskar Technologies as the exclusive distributor for its family of fluorescence imaging technologies in India. The relationship between the...

Education on hygiene and sanitation is the need of the hour in India

Even after 66 years of independence, 60% of the rural population of India has no toilet facilities, although the figure is less than 9% in urban India.1 2 India launched the Nirmal Bharat Abhiyan... ...

Which doctors have been shortlisted for the BMJ Awards India 2014?

We received more than 500 high quality nominations for the first BMJ Awards India, showing medical excellence in diverse work throughout India.1 2 The BMJ team in India had the unenviable task of... ...

India’s generics industry hires consultant to boost image

Companies specializing in generic pharmaceuticals in India and the U.S. have retained India First Group to promote the benefits of affordable access to medicine as vital to improving healthcare worldw...

Judging the best of Indian healthcare

“We received an overwhelming number of nominations,” said Anand Ekambaram, managing director of BMJ India. More than 500 individuals and teams throughout India have been put forward.1“The BMJ In...

BIO Provides Recommendations for Growing India’s Biotech Industry

BIO and the Association of Biotechnology Led Enterprises (ABLE) released a new report today, entitled Accelerating Growth: Forging India’s Bioeconomy, which present recommendations in support the gr...

Cipla in deal to set up a manufacturing unit in Iran

Indian drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing unit in that country, reports India’s Economic Times.

Matching PubMed Articles

Future and Training of Craniofacial Surgery in India.

Craniofacial surgery, in the strictest sense, is the surgery of structures above and behind the maxilla. Craniofacial surgery is not new to India and has been around for more than 4 decades now since ...

"I pick you": the impact of fairness and race on infants' selection of social partners.

By 15 months of age infants are sensitive to violations of fairness norms as assessed via their enhanced visual attention to unfair versus fair outcomes in violation-of-expectation paradigms. The curr...

Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India.

Cervical cancer is the leading cause of cancer mortality among women in India. Because Pap smear screening is not feasible in India, we need to develop effective alternatives.

Why are clinical trials necessary in India?

Clinical trials are emerging as an important activity in India as it is an essential component of the drug discovery and development program to which India is committed. The only robust way to evaluat...

Tackling antibiotic resistance in India.

Infectious diseases are major causes of mortality in India. This is aggravated by the increasing prevalence of antimicrobial resistance (AMR) both in the community and in hospitals. Due to the emergen...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement